All Quantitative Report

Argus•May 05, 2021

VNDA: Rating decreased to a HOLD

Symbols

Sector(s)

Healthcare

Rating

Current Price

$4.97

Price Target

Earnings Estimate

Summary

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet m

Subscribe to Yahoo Finance Plus Essential for full access

Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level

Actions

Download Full Report

Related Reports

View more related reports